FDC Limited, originally founded in 1936 as Fairdeal Corporation, is a leading Indian pharmaceutical company that focuses on the development, manufacturing, and marketing of pharmaceutical products. The company is well-regarded for its specialised formulations in various therapeutic areas, such as anti-infectives, gastrointestinals, ophthalmics, and more.
FDC announced that it has received final approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) concerning Cefixime 400 mg tablets. This news was shared towards the end of market hours on December 18, 2024.
Cefixime is an antibiotic used to treat bacterial infections in different parts of the body. It belongs to the cephalosporin class of medicines, functioning by either killing bacteria or inhibiting their growth. However, it is worth noting that this medication is ineffective against colds, flu, or other virus infections.
The US drug regulatory authority conducted an inspection of the company’s manufacturing plant situated in Baddi, Himachal Pradesh, in August 2024. On 13 November 2024, the USFDA issued the establishment inspection report (EIR) with no observations (Zero 483s).
FDC Limited has released its unaudited financial results for the second quarter (Q2) and the first half of the year ending 30 September 2024 (FY25), demonstrating a consistent improvement in performance. The company reported net sales of ₹513.85 crore for Q2 FY25, which is a 5.7% increase from ₹486.37 crore during the same period last year.
The net profit for the quarter reached ₹72.04 crore, representing a 3.2% rise from ₹69.80 crore in Q2 FY24. Significantly, the profit before tax (PBT) soared by 82.3% to ₹134.29 crore in Q2 FY25, compared to ₹73.68 crore in the equivalent quarter of the previous year, illustrating robust operational performance.
At 1:53 PM, FDC Ltd. was trading at ₹512.00 on the NSE, with a nearly 1% decrease.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.
Published on: Dec 19, 2024, 3:08 PM IST
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
